If you are switching from tirzepatide to retatrutide , allow an appropriate washout period and start retatrutide at the beginning of its titration schedule rather than jumping to a dose equivalent to your tirzepatide dose
The extracellular matrix and insulin resistance
It is expected to be administered weekly, starting with a lower dose to minimise side effects (1) Retatrutide has some common side effects (1), similar to Wegovy and Mounjaro, including: Nausea Vomiting Constipation Diarrhoea Since retatrutide can help increase weight loss in an additional way to Wegovy and Mounjaro, these side effects could be more intense (1)
Appetite rebounds, often exceeding pre-treatment levels in the short term
Prednisone does not require a strict diet, but certain food choices can help manage its side effects
Cardiovascular Emerging Evidence Evidence Rating: Emerging (Preliminary animal data) Cardiovascular applications are less studied but intriguing: Cardiac protection Arrhythmia prevention Blood vessel healing Collateral vessel formation Regulatory Status FDA Classification BPC-157 is not approved by the FDA for any medical use in humans